Editorial: Novel and emerging therapies in heart failure

Grigorios Giamouzis; Andrew Xanthopoulos; Konstantinos Dean Boudoulas; Georgios Karagiannis; John Skoularigis; Filippos Triposkiadis

doi:10.3389/fcvm.2023.1179352

Editorial: Novel and emerging therapies in heart failure

Front Cardiovasc Med. 2023 Mar 23:10:1179352. doi: 10.3389/fcvm.2023.1179352. eCollection 2023.

Authors

Grigorios Giamouzis^{1

2}, Andrew Xanthopoulos¹, Konstantinos Dean Boudoulas³, Georgios Karagiannis⁴, John Skoularigis^{1

2}, Filippos Triposkiadis^{1

2}

Affiliations

¹ Cardiology Department, General University Hospital of Larissa, Larissa, Greece.
² Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.
³ Division of Cardiovascular Medicine, The Ohio State University, Columbus, OH, United States.
⁴ Transplant Department, Harefield Hospital and Cardiology Department, Hillingdon Hospital, London, United Kingdom.

No abstract available

Keywords: HFpEF – heart failure with preserved ejection fraction; HFrEF – heart failure with reduced ejection fraction; acute; chronic; comorbidities; emerging therapies; heart failure; novel therapies.

Publication types

Editorial